Elin Richardsen

University Hospital of North Norway

Papers

1

Total Citations

3

H-Index

1

About

Elin Richardsen is a clinical researcher whose work centers on patient-reported outcomes following curative treatment for prostate cancer, with a particular focus on the comparative toxicities and health-related quality of life after prostatectomy, primary radiotherapy, and salvage radiotherapy. Her major contribution lies in advancing the understanding of how contemporary treatment techniques affect patients’ lived experiences, addressing critical gaps in evidence where traditional clinical trials often lack standardized patient-reported outcome measures (PROMs). By emphasizing the importance of capturing adverse health outcomes directly from patients, Richardsen’s research helps clinicians and patients make more informed, personalized treatment decisions. Her most-cited paper from 2023, which has already garnered early attention, underscores the pressing need for robust, patient-centered data in an era of evolving therapeutic modalities. Through her work, Richardsen is shaping a more nuanced conversation around survivorship and long-term wellbeing, ensuring that the patient voice remains central to the evaluation of prostate cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University Hospital of North Norway

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago